In addition, cadherin switching contributes to tumor metastasis, characterized by the transition from E-cadherin to N-cadherin or a reduction in E-cadherin levels accompanied by an upregulation of P- and R-cadherin expression within tumor tissues [33, 37, 38]. This evidence concerns the gene CDH17 and neoplasm.